| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0063 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |